1 Tarantino G,Finelli C.Syste Matic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease.Future Microbiol,2015,10:889-902.
2 Mykhal'chyshyn HP,Bodnar PM,Kobyliak NM.Correlation of adiponectin in patients with type 2 diabetes with nonalcoholic fatty liver disease depending on transa minases level.Lik Sprava,2014,May-Jun:130-138.
3 Fan JG,Farrell GC.Epidemiology of non-alcoholic fatty liver disease in China.JHepatol,2009,50:204-210.
4 Wanezaki S,Tachibana N,Nagata M,et al.Soyβ-conglycinin im proves obesity-induced metabolic abnormalities in a rat Model of nonalcoholic fatty liver disease.Obes Res Clin Pract,2015,9:168-174.
5 Okita K,Iwahashi H,Kozawa J,et al.Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy.Endocr J,2013,60:283-290.
6 中华人民共和国卫生部.医院感染诊断标准(试行).中华医学杂志,2001,81:314-320.
7 Aller R,De Luis DA,Izaola O,et al.Effect of a probiotic on liver a minotransferases in nonalcoholic fatty liver disease patients:a double blind rando mized clinicaltrial.Eur Rev Med Pharmacol Sci,2011,15:1090-1095.
8 张诤,潘勤,段晓燕,等.慢性乙型肝炎病毒感染合并非酒精性脂肪性肝病动物模型的建立与鉴定.中华肝脏病杂志,2011,19:658-663.
9 Radetti G,Kleon W,Stuefer J,et al.Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr,2006,95:833-837.
10 Ariffin H,Navaratna MP,Kee TK.et al.Antibiotic resistance patterns in nosocomial gra m-negative bacterial infections in units with heavy antibiotic usage.JTrop Pediatr,2004,50:26-31.
11 Zuckerman MJ,Menzies IS,Ho H,et al.Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes.Dig Dis Sci,2004,49:621-626.
12 Ah med MH,Byrne CD. Non-Alcoholic Fatty Liver Disease// Byrne CD,Wild SH. the Metabolic Syndro me,second ed. UK:Wiley-Black well,2011,7:245-277.
13 Ong JP,Younossi ZM.Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. Clin Liver Dis,2005,9:617-634.
14 Han DW.Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World JGastronenterol,2002,8:961-965.
15 Alisi A,Ceccarelli S,Panera N,et al.Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis.Front Cell Infect Microbiol,2012,2:132.
16 Polyzos SA,Kountouras J,Papatheodorou A,et al.Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism,2013,62:121-126. |
